Jim Cramer Recently Talked About These 9 Stocks

2. Merck & Co., Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 91

A caller mentioned that they feel in limbo with Merck & Co., Inc. (NYSE:MRK) and do not know whether to sell or hold onto it. In response, Cramer said:

“You know, first of all, you’re not alone. St. Merck, as we used to call it, has turned into just a complete nightmare. I think that if you buy Merck at a 4% yield though, you’re gonna do well. It did touch $76 today. It’s back to $81. I feel for what you’re doing… It is remarkable how poorly this stock acts. I do want you to stay the course with it right at this point. And I’m sorry because it is been a real tough one.”

Merck (NYSE:MRK) produces a variety of medicines across several health areas. Its work includes cancer treatments, vaccines, and products for animal health. On March 10, Cramer was bullish on the stock as he said:

“Okay, Merck is too cheap. I mean, it’s got a 3.4% yield. Rob Davis is doing very well. It’s really, he’s made a couple acquisitions. I think they’re gonna work out and everyone’s just so scared of the Keytruda patent (the drug has patent protection into 2028) … and that’s not anywhere near. I think you buy the stock of Merck.”